Evistia Confirms Strategic Investment in Quantova’s Post-Quantum Infrastructure Initiative

United States, 15th May 2026 – Evistia has confirmed a strategic investment in Quantova’s US entity, formalizing its participation in the Quantova ecosystem through an equity position tied to the company’s broader infrastructure development efforts. The investment centers around Quantova’s post-quantum computational and cryptographic architecture,… Read More

CytoMed Therapeutics Limited is accelerating its international expansion

CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable donor-derived cell-based immunotherapies for the treatment of a broad range of cancers, including both blood and solid tumors, The company  announced… Read More